Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.88 BRL | +5.17% | +4.91% | -0.06% |
Mar. 12 | Cosmetics group Natura's shares rise with higher margin, dividends even as loss widens | RE |
Mar. 12 | Transcript : Natura &Co Holding S.A., Q4 2023 Earnings Call, Mar 12, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.86 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company benefits from high valuations in earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.06% | 4.41B | B+ | ||
-3.33% | 250B | B- | ||
+10.09% | 19.15B | B+ | ||
0.00% | 17.54B | - | - | |
-1.32% | 10.84B | A- | ||
-7.73% | 10.22B | A- | ||
+3.86% | 6.53B | B+ | ||
+9.76% | 6B | B | ||
-16.98% | 3.78B | C- | ||
-6.25% | 3.58B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NTCO3 Stock
- Ratings Natura &Co Holding S.A.